ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1233

Synovial Joint Transcriptomic Differences in Individuals with Knee Osteoarthritis and Neuropathic Pain Symptomology

Joseph Lesnak1, Michael Zuscik2, Michael Dayton2, Craig Hogan2, Prabil Kaini2, Andrew Clauw3, Jennifer Seifert4, Michael Clay5, Theodore Price1 and Larry Moreland6, 1University of Texas at Dallas, Dallas, 2University of Colorado School of Medicine, Aurora, 3Univ of Colorado, Aurora, CO, 4University of Colorado and Oklahoma Medical Research Foundation, Aurora, CO, 5University of Colorado, Aurora, CO, 6University of Colorado, Denver, CO

Meeting: ACR Convergence 2025

Keywords: Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1221–1247) Pain in Rheumatic Disease Including Fibromyalgia Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis (OA) is a painful disease of the synovial joint and is the most common form of arthritis with a large global burden. A subset of individuals with knee OA complain of neuropathic type pain with symptomology of burning, paresthesia, and spontaneous pain in the affected joint. Since nociceptive and neuropathic pain components may require different treatment strategies, it is imperative to understand mechanisms underlying each symptomology. However, it is unknown how changes in the joint may be driving neuropathic like symptoms. Thus, we set out to compare transcriptomic data of synovial joint samples between individuals with and without neuropathic type pain undergoing joint replacement for knee OA.

Methods: A total of 35 individuals (10 males, 25 females) were enrolled who were diagnosed with knee OA by an orthopedic surgeon and undergoing total knee arthroplasty surgery. All individuals completed the painDETECT questionnaire prior to surgery to determine level of neuropathic pain symptomology. Synovial joint samples from the surgical knee were collected and frozen in pulverized dry ice. A painDETECT cutoff score of ≤12 was used to group individuals into low or moderate/high probability of neuropathic pain. RNA was extracted from tissues and bulk RNA sequencing was performed to compare transcriptomic differences between individuals with low (n=25, 8 males, 17 females) and moderate/high painDETECT scores (n=10, 2 males, 8 females). To determine differentially expressed genes (DEGs), the R package DESeq was used to compare differences between low and moderate/high painDETECT score, with sex run as a covariate (DEG: log2fc >0.585, adjusted p-value < 0.1). To make predictions surrounding synovial joint to nociceptor signaling, a ligand receptor interactome was used to intersect upregulated DEG’s encoding for ligands with their known receptors on human nociceptive neurons.

Results: A total of 121 DEGs were identified with 115 upregulated and 6 downregulated. Gene pathway assessment of the upregulated genes revealed enrichment of genes responsible for neutrophil degranulation and extracellular matrix organization. The ligand receptor interactome revealed potential interactions between 5 ligands and 24 receptors on human nociceptive neurons. This included interactions with neurotrophic factors such as L1CAM, CBLN4, and NRXN3. These neurotrophic factors bind to several receptors on neurons which have been shown to drive increased nerve growth including DCC, EGFR, and NEO1.

Conclusion: We found a set of upregulated genes specific to individuals with knee OA who complain of neuropathic like pain. These genes revealed potential enhancement of neutrophil degranulation and increased neurite growth in individuals with neuropathic symptoms. Future work will look to validate these targets using cultured human dorsal root ganglion neurons.


Disclosures: J. Lesnak: None; M. Zuscik: None; M. Dayton: None; C. Hogan: None; P. Kaini: None; A. Clauw: None; J. Seifert: None; M. Clay: None; T. Price: None; L. Moreland: None.

To cite this abstract in AMA style:

Lesnak J, Zuscik M, Dayton M, Hogan C, Kaini P, Clauw A, Seifert J, Clay M, Price T, Moreland L. Synovial Joint Transcriptomic Differences in Individuals with Knee Osteoarthritis and Neuropathic Pain Symptomology [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/synovial-joint-transcriptomic-differences-in-individuals-with-knee-osteoarthritis-and-neuropathic-pain-symptomology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-joint-transcriptomic-differences-in-individuals-with-knee-osteoarthritis-and-neuropathic-pain-symptomology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology